1 Study Coverage 1.1 Anti-Retroviral Drugs Product Introduction 1.2 Market by Type 1.2.1 Global Anti-Retroviral Drugs Market Size Growth Rate by Type 1.4.2 Protease Inhibitors 1.4.3 Non-Nucleoside Reverse Transcriptase Inhibitors 1.2.4 Integrase Inhibitors 1.2.5 Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors 1.3 Market by Application 1.3.1 Global Anti-Retroviral Drugs Market Size Growth Rate by Application 1.3.2 Hepatitis 1.3.3 HIV/AIDS 1.3.4 Herpes 1.3.5 Influenza 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Anti-Retroviral Drugs Sales Estimates and Forecasts 2016-2027 2.2 Global Anti-Retroviral Drugs Revenue Estimates and Forecasts 2016-2027 2.3 Global Anti-Retroviral Drugs Revenue by Region: 2016 VS 2021 VS 2027 2.4 Global Top Anti-Retroviral Drugs Regions by Sales 2.4.1 Global Top Anti-Retroviral Drugs Regions by Sales (2016-2021) 2.4.2 Global Top Anti-Retroviral Drugs Regions by Sales (2022-2027) 2.5 Global Top Anti-Retroviral Drugs Regions by Revenue 2.5.1 Global Top Anti-Retroviral Drugs Regions by Revenue (2016-2021) 2.5.2 Global Top Anti-Retroviral Drugs Regions by Revenue (2022-2027) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Anti-Retroviral Drugs Sales by Manufacturers 3.1.1 Global Top Anti-Retroviral Drugs Manufacturers by Sales (2016-2021) 3.1.2 Global Top Anti-Retroviral Drugs Manufacturers Market Share by Sales (2016-2021) 3.1.3 Global Top 10 and Top 5 Companies by Anti-Retroviral Drugs Sales in 2020 3.2 Global Anti-Retroviral Drugs Revenue by Manufacturers 3.2.1 Global Top Anti-Retroviral Drugs Manufacturers by Revenue (2016-2021) 3.2.2 Global Top Anti-Retroviral Drugs Manufacturers Market Share by Revenue (2016-2021) 3.2.3 Global Top 10 and Top 5 Companies by Anti-Retroviral Drugs Revenue in 2020 3.3 Global Anti-Retroviral Drugs Sales Price by Manufacturers 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Anti-Retroviral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Anti-Retroviral Drugs Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Anti-Retroviral Drugs Sales by Type 4.1.1 Global Anti-Retroviral Drugs Historical Sales by Type (2016-2021) 4.1.2 Global Anti-Retroviral Drugs Forecasted Sales by Type (2022-2027) 4.1.3 Global Anti-Retroviral Drugs Sales Market Share by Type (2016-2027) 4.2 Global Anti-Retroviral Drugs Revenue by Type 4.2.1 Global Anti-Retroviral Drugs Historical Revenue by Type (2016-2021) 4.2.2 Global Anti-Retroviral Drugs Forecasted Revenue by Type (2022-2027) 4.2.3 Global Anti-Retroviral Drugs Revenue Market Share by Type (2016-2027) 4.3 Global Anti-Retroviral Drugs Price by Type 4.3.1 Global Anti-Retroviral Drugs Price by Type (2016-2021) 4.3.2 Global Anti-Retroviral Drugs Price Forecast by Type (2022-2027) 5 Market Size by Application 5.1 Global Anti-Retroviral Drugs Sales by Application 5.1.1 Global Anti-Retroviral Drugs Historical Sales by Application (2016-2021) 5.1.2 Global Anti-Retroviral Drugs Forecasted Sales by Application (2022-2027) 5.1.3 Global Anti-Retroviral Drugs Sales Market Share by Application (2016-2027) 5.2 Global Anti-Retroviral Drugs Revenue by Application 5.2.1 Global Anti-Retroviral Drugs Historical Revenue by Application (2016-2021) 5.2.2 Global Anti-Retroviral Drugs Forecasted Revenue by Application (2022-2027) 5.2.3 Global Anti-Retroviral Drugs Revenue Market Share by Application (2016-2027) 5.3 Global Anti-Retroviral Drugs Price by Application 5.3.1 Global Anti-Retroviral Drugs Price by Application (2016-2021) 5.3.2 Global Anti-Retroviral Drugs Price Forecast by Application (2022-2027) 6 North America 6.1 North America Anti-Retroviral Drugs Market Size by Type 6.1.1 North America Anti-Retroviral Drugs Sales by Type (2016-2027) 6.1.2 North America Anti-Retroviral Drugs Revenue by Type (2016-2027) 6.2 North America Anti-Retroviral Drugs Market Size by Application 6.2.1 North America Anti-Retroviral Drugs Sales by Application (2016-2027) 6.2.2 North America Anti-Retroviral Drugs Revenue by Application (2016-2027) 6.3 North America Anti-Retroviral Drugs Market Size by Country 6.3.1 North America Anti-Retroviral Drugs Sales by Country (2016-2027) 6.3.2 North America Anti-Retroviral Drugs Revenue by Country (2016-2027) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Anti-Retroviral Drugs Market Size by Type 7.1.1 Europe Anti-Retroviral Drugs Sales by Type (2017-2027) 7.1.2 Europe Anti-Retroviral Drugs Revenue by Type (2017-2027) 7.2 Europe Anti-Retroviral Drugs Market Size by Application 7.2.1 Europe Anti-Retroviral Drugs Sales by Application (2017-2027) 7.2.2 Europe Anti-Retroviral Drugs Revenue by Application (2017-2027) 7.3 Europe Anti-Retroviral Drugs Market Size by Country 7.3.1 Europe Anti-Retroviral Drugs Sales by Country (2017-2027) 7.3.2 Europe Anti-Retroviral Drugs Revenue by Country (2017-2027) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Anti-Retroviral Drugs Market Size by Type 8.1.1 Asia Pacific Anti-Retroviral Drugs Sales by Type (2018-2027) 8.1.2 Asia Pacific Anti-Retroviral Drugs Revenue by Type (2018-2027) 8.2 Asia Pacific Anti-Retroviral Drugs Market Size by Application 8.2.1 Asia Pacific Anti-Retroviral Drugs Sales by Application (2018-2027) 8.2.2 Asia Pacific Anti-Retroviral Drugs Revenue by Application (2018-2027) 8.3 Asia Pacific Anti-Retroviral Drugs Market Size by Region 8.3.1 Asia Pacific Anti-Retroviral Drugs Sales by Region (2018-2027) 8.3.2 Asia Pacific Anti-Retroviral Drugs Revenue by Region (2018-2027) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Anti-Retroviral Drugs Market Size by Type 9.1.1 Latin America Anti-Retroviral Drugs Sales by Type (2019-2027) 9.1.2 Latin America Anti-Retroviral Drugs Revenue by Type (2019-2027) 9.2 Latin America Anti-Retroviral Drugs Market Size by Application 9.2.1 Latin America Anti-Retroviral Drugs Sales by Application (2019-2027) 9.2.2 Latin America Anti-Retroviral Drugs Revenue by Application (2019-2027) 9.3 Latin America Anti-Retroviral Drugs Market Size by Country 9.3.1 Latin America Anti-Retroviral Drugs Sales by Country (2019-2027) 9.3.2 Latin America Anti-Retroviral Drugs Revenue by Country (2019-2027) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 6 Middle East and Africa 6.1 Middle East and Africa Anti-Retroviral Drugs Market Size by Type 6.1.1 Middle East and Africa Anti-Retroviral Drugs Sales by Type (2016-2027) 6.1.2 Middle East and Africa Anti-Retroviral Drugs Revenue by Type (2016-2027) 6.2 Middle East and Africa Anti-Retroviral Drugs Market Size by Application 6.2.1 Middle East and Africa Anti-Retroviral Drugs Sales by Application (2016-2027) 6.2.2 Middle East and Africa Anti-Retroviral Drugs Revenue by Application (2016-2027) 6.3 Middle East and Africa Anti-Retroviral Drugs Market Size by Country 6.3.1 Middle East and Africa Anti-Retroviral Drugs Sales by Country (2016-2027) 6.3.2 Middle East and Africa Anti-Retroviral Drugs Revenue by Country (2016-2027) 6.3.3 Turkey 6.3.4 Saudi Arabia 6.3.5 U.A.E 11 Company Profiles 11.1 Cardionet 11.1.1 Cardionet Corporation Information 11.1.2 Cardionet Overview 11.1.3 Cardionet Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Cardionet Anti-Retroviral Drugs Product Description 11.1.5 Cardionet Related Developments 11.2 GE Healthcare 11.2.1 GE Healthcare Corporation Information 11.2.2 GE Healthcare Overview 11.2.3 GE Healthcare Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.2.4 GE Healthcare Anti-Retroviral Drugs Product Description 11.2.5 GE Healthcare Related Developments 11.3 Abbott 11.3.1 Abbott Corporation Information 11.3.2 Abbott Overview 11.3.3 Abbott Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.3.4 Abbott Anti-Retroviral Drugs Product Description 11.3.5 Abbott Related Developments 11.4 AstraZeneca 11.4.1 AstraZeneca Corporation Information 11.4.2 AstraZeneca Overview 11.4.3 AstraZeneca Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.4.4 AstraZeneca Anti-Retroviral Drugs Product Description 11.4.5 AstraZeneca Related Developments 11.5 Bristol-Myers-Squibb 11.5.1 Bristol-Myers-Squibb Corporation Information 11.5.2 Bristol-Myers-Squibb Overview 11.5.3 Bristol-Myers-Squibb Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.5.4 Bristol-Myers-Squibb Anti-Retroviral Drugs Product Description 11.5.5 Bristol-Myers-Squibb Related Developments 11.6 Gilead 11.6.1 Gilead Corporation Information 11.6.2 Gilead Overview 11.6.3 Gilead Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.6.4 Gilead Anti-Retroviral Drugs Product Description 11.6.5 Gilead Related Developments 11.7 Cardiac Science Corp. 11.7.1 Cardiac Science Corp. Corporation Information 11.7.2 Cardiac Science Corp. Overview 11.7.3 Cardiac Science Corp. Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.7.4 Cardiac Science Corp. Anti-Retroviral Drugs Product Description 11.7.5 Cardiac Science Corp. Related Developments 11.8 Cardiocom 11.8.1 Cardiocom Corporation Information 11.8.2 Cardiocom Overview 11.8.3 Cardiocom Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.8.4 Cardiocom Anti-Retroviral Drugs Product Description 11.8.5 Cardiocom Related Developments 11.9 Biotelemetry 11.9.1 Biotelemetry Corporation Information 11.9.2 Biotelemetry Overview 11.9.3 Biotelemetry Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.9.4 Biotelemetry Anti-Retroviral Drugs Product Description 11.9.5 Biotelemetry Related Developments 11.10 GlaxoSmithKline 11.10.1 GlaxoSmithKline Corporation Information 11.10.2 GlaxoSmithKline Overview 11.10.3 GlaxoSmithKline Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.10.4 GlaxoSmithKline Anti-Retroviral Drugs Product Description 11.10.5 GlaxoSmithKline Related Developments 11.1 Cardionet 11.1.1 Cardionet Corporation Information 11.1.2 Cardionet Overview 11.1.3 Cardionet Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Cardionet Anti-Retroviral Drugs Product Description 11.1.5 Cardionet Related Developments 12 Value Chain and Sales Channels Analysis 12.1 Anti-Retroviral Drugs Value Chain Analysis 12.2 Anti-Retroviral Drugs Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Anti-Retroviral Drugs Production Mode & Process 12.4 Anti-Retroviral Drugs Sales and Marketing 12.4.1 Anti-Retroviral Drugs Sales Channels 12.4.2 Anti-Retroviral Drugs Distributors 12.5 Anti-Retroviral Drugs Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Anti-Retroviral Drugs Industry Trends 13.2 Anti-Retroviral Drugs Market Drivers 13.3 Anti-Retroviral Drugs Market Challenges 13.4 Anti-Retroviral Drugs Market Restraints 14 Key Findings in The Global Anti-Retroviral Drugs Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Anti-Retroviral Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Protease Inhibitors Table 3. Major Manufacturers of Non-Nucleoside Reverse Transcriptase Inhibitors Table 4. Major Manufacturers of Integrase Inhibitors Table 5. Major Manufacturers of Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors Table 6. Global Anti-Retroviral Drugs Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 7. Global Anti-Retroviral Drugs Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 8. Global Anti-Retroviral Drugs Sales by Region (2016-2021) & (K Pcs) Table 9. Global Anti-Retroviral Drugs Sales Market Share by Region (2016-2021) Table 10. Global Anti-Retroviral Drugs Sales by Region (2016-2021) & (K Pcs) Table 11. Global Anti-Retroviral Drugs Sales Market Share by Region (2022-2027) Table 12. Global Anti-Retroviral Drugs Revenue by Region (2016-2021) & (US$ Million) Table 13. Global Anti-Retroviral Drugs Revenue Market Share by Region (2016-2021) Table 14. Global Anti-Retroviral Drugs Revenue by Region (2022-2027) & (US$ Million) Table 15. Global Anti-Retroviral Drugs Revenue Market Share by Region (2022-2027) Table 16. Global Anti-Retroviral Drugs Sales by Manufacturers (2016-2021) & (K Pcs) Table 17. Global Anti-Retroviral Drugs Sales Share by Manufacturers (2016-2021) Table 18. Global Anti-Retroviral Drugs Revenue by Manufacturers (2016-2021) & (US$ Million) Table 19. Global Anti-Retroviral Drugs Revenue Share by Manufacturers (2016-2021) Table 20. Anti-Retroviral Drugs Price by Manufacturers 2016-2021 (USD/Pcs) Table 21. Global Anti-Retroviral Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 22. Global Anti-Retroviral Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Retroviral Drugs as of 2020) Table 23. Anti-Retroviral Drugs Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Anti-Retroviral Drugs Product Offered Table 25. Date of Manufacturers Enter into Anti-Retroviral Drugs Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Anti-Retroviral Drugs Sales by Type (2016-2021) & (K Pcs) Table 28. Global Anti-Retroviral Drugs Sales by Type (2022-2027) & (K Pcs) Table 29. Global Anti-Retroviral Drugs Sales Share by Type (2016-2021) Table 30. Global Anti-Retroviral Drugs Sales Share by Type (2022-2027) Table 31. Global Anti-Retroviral Drugs Revenue by Type (2016-2021) & (US$ Million) Table 32. Global Anti-Retroviral Drugs Revenue by Type (2022-2027) & (US$ Million) Table 33. Global Anti-Retroviral Drugs Revenue Share by Type (2016-2021) Table 34. Global Anti-Retroviral Drugs Revenue Share by Type (2022-2027) Table 35. Anti-Retroviral Drugs Price by Type (2016-2021) & (USD/Pcs) Table 36. Global Anti-Retroviral Drugs Price Forecast by Type (2022-2027) & (USD/Pcs) Table 37. Global Anti-Retroviral Drugs Sales by Application (2016-2021) & (K Pcs) Table 38. Global Anti-Retroviral Drugs Sales by Application (2022-2027) & (K Pcs) Table 39. Global Anti-Retroviral Drugs Sales Share by Application (2016-2021) Table 40. Global Anti-Retroviral Drugs Sales Share by Application (2022-2027) Table 41. Global Anti-Retroviral Drugs Revenue by Application (2016-2021) & (US$ Million) Table 42. Global Anti-Retroviral Drugs Revenue by Application (2022-2027) & (US$ Million) Table 43. Global Anti-Retroviral Drugs Revenue Share by Application (2016-2021) Table 44. Global Anti-Retroviral Drugs Revenue Share by Application (2022-2027) Table 45. Anti-Retroviral Drugs Price by Application (2016-2021) & (USD/Pcs) Table 46. Global Anti-Retroviral Drugs Price Forecast by Application (2022-2027) & (USD/Pcs) Table 47. North America Anti-Retroviral Drugs Sales by Type (2016-2021) & (K Pcs) Table 48. North America Anti-Retroviral Drugs Sales by Type (2022-2027) & (K Pcs) Table 49. North America Anti-Retroviral Drugs Revenue by Type (2016-2021) & (US$ Million) Table 50. North America Anti-Retroviral Drugs Revenue by Type (2022-2027) & (US$ Million) Table 51. North America Anti-Retroviral Drugs Sales by Application (2016-2021) & (K Pcs) Table 52. North America Anti-Retroviral Drugs Sales by Application (2022-2027) & (K Pcs) Table 53. North America Anti-Retroviral Drugs Revenue by Application (2016-2021) & (US$ Million) Table 54. North America Anti-Retroviral Drugs Revenue by Application (2022-2027) & (US$ Million) Table 55. North America Anti-Retroviral Drugs Sales by Country (2016-2021) & (K Pcs) Table 56. North America Anti-Retroviral Drugs Sales by Country (2022-2027) & (K Pcs) Table 57. North America Anti-Retroviral Drugs Revenue by Country (2016-2021) & (US$ Million) Table 58. North America Anti-Retroviral Drugs Revenue by Country (2022-2027) & (US$ Million) Table 59. Europe Anti-Retroviral Drugs Sales by Type (2016-2021) & (K Pcs) Table 60. Europe Anti-Retroviral Drugs Sales by Type (2022-2027) & (K Pcs) Table 61. Europe Anti-Retroviral Drugs Revenue by Type (2016-2021) & (US$ Million) Table 62. Europe Anti-Retroviral Drugs Revenue by Type (2022-2027) & (US$ Million) Table 63. Europe Anti-Retroviral Drugs Sales by Application (2016-2021) & (K Pcs) Table 64. Europe Anti-Retroviral Drugs Sales by Application (2022-2027) & (K Pcs) Table 65. Europe Anti-Retroviral Drugs Revenue by Application (2016-2021) & (US$ Million) Table 66. Europe Anti-Retroviral Drugs Revenue by Application (2022-2027) & (US$ Million) Table 67. Europe Anti-Retroviral Drugs Sales by Country (2016-2021) & (K Pcs) Table 68. Europe Anti-Retroviral Drugs Sales by Country (2022-2027) & (K Pcs) Table 69. Europe Anti-Retroviral Drugs Revenue by Country (2016-2021) & (US$ Million) Table 70. Europe Anti-Retroviral Drugs Revenue by Country (2022-2027) & (US$ Million) Table 71. Asia Pacific Anti-Retroviral Drugs Sales by Type (2016-2021) & (K Pcs) Table 72. Asia Pacific Anti-Retroviral Drugs Sales by Type (2022-2027) & (K Pcs) Table 73. Asia Pacific Anti-Retroviral Drugs Revenue by Type (2016-2021) & (US$ Million) Table 74. Asia Pacific Anti-Retroviral Drugs Revenue by Type (2022-2027) & (US$ Million) Table 75. Asia Pacific Anti-Retroviral Drugs Sales by Application (2016-2021) & (K Pcs) Table 76. Asia Pacific Anti-Retroviral Drugs Sales by Application (2022-2027) & (K Pcs) Table 77. Asia Pacific Anti-Retroviral Drugs Revenue by Application (2016-2021) & (US$ Million) Table 78. Asia Pacific Anti-Retroviral Drugs Revenue by Application (2022-2027) & (US$ Million) Table 79. Asia Pacific Anti-Retroviral Drugs Sales by Region (2016-2021) & (K Pcs) Table 80. Asia Pacific Anti-Retroviral Drugs Sales by Region (2022-2027) & (K Pcs) Table 81. Asia Pacific Anti-Retroviral Drugs Revenue by Region (2016-2021) & (US$ Million) Table 82. Asia Pacific Anti-Retroviral Drugs Revenue by Region (2022-2027) & (US$ Million) Table 83. Latin America Anti-Retroviral Drugs Sales by Type (2016-2021) & (K Pcs) Table 84. Latin America Anti-Retroviral Drugs Sales by Type (2022-2027) & (K Pcs) Table 85. Latin America Anti-Retroviral Drugs Revenue by Type (2016-2021) & (US$ Million) Table 86. Latin America Anti-Retroviral Drugs Revenue by Type (2022-2027) & (US$ Million) Table 87. Latin America Anti-Retroviral Drugs Sales by Application (2016-2021) & (K Pcs) Table 88. Latin America Anti-Retroviral Drugs Sales by Application (2022-2027) & (K Pcs) Table 89. Latin America Anti-Retroviral Drugs Revenue by Application (2016-2021) & (US$ Million) Table 90. Latin America Anti-Retroviral Drugs Revenue by Application (2022-2027) & (US$ Million) Table 91. Latin America Anti-Retroviral Drugs Sales by Country (2016-2021) & (K Pcs) Table 92. Latin America Anti-Retroviral Drugs Sales by Country (2022-2027) & (K Pcs) Table 93. Latin America Anti-Retroviral Drugs Revenue by Country (2016-2021) & (US$ Million) Table 94. Latin America Anti-Retroviral Drugs Revenue by Country (2022-2027) & (US$ Million) Table 95. Middle East and Africa Anti-Retroviral Drugs Sales by Type (2016-2021) & (K Pcs) Table 96. Middle East and Africa Anti-Retroviral Drugs Sales by Type (2022-2027) & (K Pcs) Table 97. Middle East and Africa Anti-Retroviral Drugs Revenue by Type (2016-2021) & (US$ Million) Table 98. Middle East and Africa Anti-Retroviral Drugs Revenue by Type (2022-2027) & (US$ Million) Table 99. Middle East and Africa Anti-Retroviral Drugs Sales by Application (2016-2021) & (K Pcs) Table 100. Middle East and Africa Anti-Retroviral Drugs Sales by Application (2022-2027) & (K Pcs) Table 101. Middle East and Africa Anti-Retroviral Drugs Revenue by Application (2016-2021) & (US$ Million) Table 102. Middle East and Africa Anti-Retroviral Drugs Revenue by Application (2022-2027) & (US$ Million) Table 103. Middle East and Africa Anti-Retroviral Drugs Sales by Country (2016-2021) & (K Pcs) Table 104. Middle East and Africa Anti-Retroviral Drugs Sales by Country (2022-2027) & (K Pcs) Table 105. Middle East and Africa Anti-Retroviral Drugs Revenue by Country (2016-2021) & (US$ Million) Table 106. Middle East and Africa Anti-Retroviral Drugs Revenue by Country (2022-2027) & (US$ Million) Table 107. Cardionet Corporation Information Table 108. Cardionet Description and Major Businesses Table 109. Cardionet Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 110. Cardionet Anti-Retroviral Drugs Product Table 111. Cardionet Recent Developments Table 112. GE Healthcare Corporation Information Table 113. GE Healthcare Description and Major Businesses Table 114. GE Healthcare Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 115. GE Healthcare Anti-Retroviral Drugs Product Table 116. GE Healthcare Recent Developments Table 117. Abbott Corporation Information Table 118. Abbott Description and Major Businesses Table 119. Abbott Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 120. Abbott Anti-Retroviral Drugs Product Table 121. Abbott Recent Developments Table 122. AstraZeneca Corporation Information Table 123. AstraZeneca Description and Major Businesses Table 124. AstraZeneca Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 125. AstraZeneca Anti-Retroviral Drugs Product Table 126. AstraZeneca Recent Developments Table 127. Bristol-Myers-Squibb Corporation Information Table 128. Bristol-Myers-Squibb Description and Major Businesses Table 129. Bristol-Myers-Squibb Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 130. Bristol-Myers-Squibb Anti-Retroviral Drugs Product Table 131. Bristol-Myers-Squibb Recent Developments Table 132. Gilead Corporation Information Table 133. Gilead Description and Major Businesses Table 134. Gilead Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 135. Gilead Anti-Retroviral Drugs Product Table 136. Gilead Recent Developments Table 137. Cardiac Science Corp. Corporation Information Table 138. Cardiac Science Corp. Description and Major Businesses Table 139. Cardiac Science Corp. Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 140. Cardiac Science Corp. Anti-Retroviral Drugs Product Table 141. Cardiac Science Corp. Recent Developments Table 142. Cardiocom Corporation Information Table 143. Cardiocom Description and Major Businesses Table 144. Cardiocom Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 145. Cardiocom Anti-Retroviral Drugs Product Table 146. Cardiocom Recent Developments Table 147. Biotelemetry Corporation Information Table 148. Biotelemetry Description and Major Businesses Table 149. Biotelemetry Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 150. Biotelemetry Anti-Retroviral Drugs Product Table 151. Biotelemetry Recent Developments Table 152. GlaxoSmithKline Corporation Information Table 153. GlaxoSmithKline Description and Major Businesses Table 154. GlaxoSmithKline Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 155. GlaxoSmithKline Anti-Retroviral Drugs Product Table 156. GlaxoSmithKline Recent Developments Table 157. Roche Corporation Information Table 158. Roche Description and Major Businesses Table 159. Roche Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 160. Roche Anti-Retroviral Drugs Product Table 161. Roche Recent Developments Table 162. Key Raw Materials Lists Table 163. Raw Materials Key Suppliers Lists Table 164. Anti-Retroviral Drugs Distributors List Table 165. Anti-Retroviral Drugs Customers List Table 166. Anti-Retroviral Drugs Market Trends Table 167. Anti-Retroviral Drugs Market Drivers Table 168. Anti-Retroviral Drugs Market Challenges Table 169. Anti-Retroviral Drugs Market Restraints Table 170. Research Programs/Design for This Report Table 171. Key Data Information from Secondary Sources Table 172. Key Data Information from Primary Sources List of Figures Figure 1. Anti-Retroviral Drugs Product Picture Figure 2. Global Anti-Retroviral Drugs Market Share by Type in 2020 & 2027 Figure 3. Protease Inhibitors Product Picture Figure 4. Non-Nucleoside Reverse Transcriptase Inhibitors Product Picture Figure 5. Integrase Inhibitors Product Picture Figure 6. Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors Product Picture Figure 7. Global Anti-Retroviral Drugs Sales Market Share by Application in 2020 & 2027 Figure 8. Hepatitis Figure 9. HIV/AIDS Figure 10. Herpes Figure 11. Influenza Figure 12. Others Figure 13. Anti-Retroviral Drugs Report Years Considered Figure 14. Global Anti-Retroviral Drugs Sales 2016-2027 (K Pcs) Figure 15. Global Anti-Retroviral Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Anti-Retroviral Drugs Revenue 2016-2027 (US$ Million) Figure 17. Global Anti-Retroviral Drugs Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 18. Global Anti-Retroviral Drugs Sales Market Share by Region (2016-2021) Figure 19. Global Anti-Retroviral Drugs Sales Market Share by Region (2022-2027) Figure 20. North America Anti-Retroviral Drugs Sales YoY (2016-2027) & (K Pcs) Figure 21. North America Anti-Retroviral Drugs Revenue YoY (2016-2027) & (US$ Million) Figure 22. Europe Anti-Retroviral Drugs Sales YoY (2016-2027) & (K Pcs) Figure 23. Europe Anti-Retroviral Drugs Revenue YoY (2016-2027) & (US$ Million) Figure 24. Asia-Pacific Anti-Retroviral Drugs Sales YoY (2016-2027) & (K Pcs) Figure 25. Asia-Pacific Anti-Retroviral Drugs Revenue YoY (2016-2027) & (US$ Million) Figure 26. Latin America Anti-Retroviral Drugs Sales YoY (2016-2027) & (K Pcs) Figure 27. Latin America Anti-Retroviral Drugs Revenue YoY (2016-2027) & (US$ Million) Figure 28. Middle East & Africa Anti-Retroviral Drugs Sales YoY (2016-2027) & (K Pcs) Figure 29. Middle East & Africa Anti-Retroviral Drugs Revenue YoY (2016-2027) & (US$ Million) Figure 30. The Top 10 and Top 5 Players Market Share by Anti-Retroviral Drugs Sales in 2020 Figure 31. The Top 10 and Top 5 Players Market Share by Anti-Retroviral Drugs Revenue in 2020 Figure 32. Anti-Retroviral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 33. Global Anti-Retroviral Drugs Sales Market Share by Type (2016-2027) Figure 34. Global Anti-Retroviral Drugs Revenue Market Share by Type (2016-2027) Figure 35. Global Anti-Retroviral Drugs Sales Market Share by Application (2016-2027) Figure 36. Global Anti-Retroviral Drugs Revenue Market Share by Application (2016-2027) Figure 37. North America Anti-Retroviral Drugs Sales Market Share by Type (2016-2027) Figure 38. North America Anti-Retroviral Drugs Revenue Market Share by Type (2016-2027) Figure 39. North America Anti-Retroviral Drugs Sales Market Share by Application (2016-2027) Figure 40. North America Anti-Retroviral Drugs Revenue Market Share by Application (2016-2027) Figure 41. North America Anti-Retroviral Drugs Sales Share by Country (2016-2027) Figure 42. North America Anti-Retroviral Drugs Revenue Share by Country (2016-2027) Figure 43. U.S. Anti-Retroviral Drugs Revenue (2016-2027) & (US$ Million) Figure 44. Canada Anti-Retroviral Drugs Revenue (2016-2027) & (US$ Million) Figure 45. Europe Anti-Retroviral Drugs Sales Market Share by Type (2016-2027) Figure 46. Europe Anti-Retroviral Drugs Revenue Market Share by Type (2016-2027) Figure 47. Europe Anti-Retroviral Drugs Sales Market Share by Application (2016-2027) Figure 48. Europe Anti-Retroviral Drugs Revenue Market Share by Application (2016-2027) Figure 49. Europe Anti-Retroviral Drugs Sales Share by Country (2016-2027) Figure 50. Europe Anti-Retroviral Drugs Revenue Share by Country (2016-2027) Figure 51. Germany Anti-Retroviral Drugs Revenue (2016-2027) & (US$ Million) Figure 52. France Anti-Retroviral Drugs Revenue (2016-2027) & (US$ Million) Figure 53. U.K. Anti-Retroviral Drugs Revenue (2016-2027) & (US$ Million) Figure 54. Italy Anti-Retroviral Drugs Revenue (2016-2027) & (US$ Million) Figure 55. Russia Anti-Retroviral Drugs Revenue (2016-2027) & (US$ Million) Figure 56. Asia Pacific Anti-Retroviral Drugs Sales Market Share by Type (2016-2027) Figure 57. Asia Pacific Anti-Retroviral Drugs Revenue Market Share by Type (2016-2027) Figure 58. Asia Pacific Anti-Retroviral Drugs Sales Market Share by Application (2016-2027) Figure 59. Asia Pacific Anti-Retroviral Drugs Revenue Market Share by Application (2016-2027) Figure 60. Asia Pacific Anti-Retroviral Drugs Sales Share by Region (2016-2027) Figure 61. Asia Pacific Anti-Retroviral Drugs Revenue Share by Region (2016-2027) Figure 62. China Anti-Retroviral Drugs Revenue (2016-2027) & (US$ Million) Figure 63. Japan Anti-Retroviral Drugs Revenue (2016-2027) & (US$ Million) Figure 64. South Korea Anti-Retroviral Drugs Revenue (2016-2027) & (US$ Million) Figure 65. India Anti-Retroviral Drugs Revenue (2016-2027) & (US$ Million) Figure 66. Australia Anti-Retroviral Drugs Revenue (2016-2027) & (US$ Million) Figure 67. Taiwan Anti-Retroviral Drugs Revenue (2016-2027) & (US$ Million) Figure 68. Indonesia Anti-Retroviral Drugs Revenue (2016-2027) & (US$ Million) Figure 69. Thailand Anti-Retroviral Drugs Revenue (2016-2027) & (US$ Million) Figure 70. Malaysia Anti-Retroviral Drugs Revenue (2016-2027) & (US$ Million) Figure 71. Philippines Anti-Retroviral Drugs Revenue (2016-2027) & (US$ Million) Figure 72. Latin America Anti-Retroviral Drugs Sales Market Share by Type (2016-2027) Figure 73. Latin America Anti-Retroviral Drugs Revenue Market Share by Type (2016-2027) Figure 74. Latin America Anti-Retroviral Drugs Sales Market Share by Application (2016-2027) Figure 75. Latin America Anti-Retroviral Drugs Revenue Market Share by Application (2016-2027) Figure 76. Latin America Anti-Retroviral Drugs Sales Share by Country (2016-2027) Figure 77. Latin America Anti-Retroviral Drugs Revenue Share by Country (2016-2027) Figure 78. Mexico Anti-Retroviral Drugs Revenue (2016-2027) & (US$ Million) Figure 79. Brazil Anti-Retroviral Drugs Revenue (2016-2027) & (US$ Million) Figure 80. Argentina Anti-Retroviral Drugs Revenue (2016-2027) & (US$ Million) Figure 81. Middle East and Africa Anti-Retroviral Drugs Sales Market Share by Type (2016-2027) Figure 82. Middle East and Africa Anti-Retroviral Drugs Revenue Market Share by Type (2016-2027) Figure 83. Middle East and Africa Anti-Retroviral Drugs Sales Market Share by Application (2016-2027) Figure 84. Middle East and Africa Anti-Retroviral Drugs Revenue Market Share by Application (2016-2027) Figure 85. Middle East and Africa Anti-Retroviral Drugs Sales Share by Country (2016-2027) Figure 86. Middle East and Africa Anti-Retroviral Drugs Revenue Share by Country (2016-2027) Figure 87. Turkey Anti-Retroviral Drugs Revenue (2016-2027) & (US$ Million) Figure 88. Saudi Arabia Anti-Retroviral Drugs Revenue (2016-2027) & (US$ Million) Figure 89. U.A.E Anti-Retroviral Drugs Revenue (2016-2027) & (US$ Million) Figure 90. Anti-Retroviral Drugs Value Chain Figure 91. Anti-Retroviral Drugs Production Process Figure 92. Channels of Distribution Figure 93. Distributors Profiles Figure 94. Bottom-up and Top-down Approaches for This Report Figure 95. Data Triangulation Figure 96. Key Executives Interviewed

Cardionet GE Healthcare Abbott AstraZeneca Bristol-Myers-Squibb Gilead Cardiac Science Corp. Cardiocom Biotelemetry GlaxoSmithKline Roche